Interleukin 28B-related polymorphisms: A pathway for understanding hepatitis C virus infection?

World Journal of Gastroenterology

Volumn 19, Issue 42, 2013, Pages 7399-7404

  Garcia, Raquel Francine Liermann ^a,b   Moreira, Simone ^a   Ramos, Ana Lucia de Araújo ^c   Ferreira, Leslie Ecker ^a   De Mattos, Angelo Alves ^d   Tovo, Cristiane Valle ^d   Nader, Lysandro Alsina ^e   Ramos, Juliene Antonio ^c   Rondinelli, Edson ^c   Dominici, Arnaldo de Jesus ^f   Garcia, Christian Evangelista ^a,b   Pinho, Mauro de Souza Leite ^a   Brandão Mello, Carlos Eduardo ^g   Villela Nogueira, Cristiane Alves ^c   de França, Paulo Henrique Condeixa ^a  

^a UNIVERSITY OF JOINVILLE REGION   (Brazil)

^b Departamento de Cirurgia do Hospital Municipal São José   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d Laboratório Experimental de Hepatologia e Gastroenterologia   (Brazil)

^e FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^f FEDERAL UNIVERSITY OF MARANHÃO   (Brazil)

^g HOSPITAL UNIVERSITÁRIO GAFFRÉE E GUINLE   (Brazil)

Author keywords

Brazil; Hepatitis C; Interleukin 28B; Single nucleotide polymorphisms; Sustained virological response

Indexed keywords

INTERLEUKIN 28B; PEGINTERFERON ALPHA2A PLUS RIBAVIRIN; PEGINTERFERON ALPHA2B PLUS RIBAVIRIN;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN POLYMORPHISM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

BRAZIL; HEPATITIS C; INTERLEUKIN 28B; SINGLE NUCLEOTIDE POLYMORPHISMS; SUSTAINED VIROLOGICAL RESPONSE;

ADULT; AGED; ANTIVIRAL AGENTS; BRAZIL; CASE-CONTROL STUDIES; DRUG THERAPY, COMBINATION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; INTERLEUKINS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PHENOTYPE; POLYETHYLENE GLYCOLS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECOMBINANT PROTEINS; RIBAVIRIN; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84887591868     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i42.7399     Document Type: Article

References (23)

1. Tsubota A, Fujise K, Namiki Y, Tada N. Peginterferon and ribavirin treatment for hepatitis C virus infection. World J Gastroenterol 2011; 17: 419-432 [PMID: 21274371 DOI: 10.3748/ wjg.v17.i4.419]
2. Shirakawa H, Matsumoto A, Joshita S, Komatsu M, Tanaka N, Umemura T, Ichijo T, Yoshizawa K, Kiyosawa K, Tanaka E. Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors. Hepatology 2008; 48: 1753-1760 [PMID: 18925643 DOI: 10.1002/hep.22543]
3. Rehermann B. Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J Clin Invest 2009; 119: 1745-1754 [PMID: 19587449 DOI: 10.1172/JCI39133]
4. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, Sulkowski M, McHutchison JG, Goldstein DB. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009; 461: 399-401 [PMID: 19684573 DOI: 10.1038/nature08309]
5. Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, Nakagawa M, Korenaga M, Hino K, Hige S, Ito Y, Mita E, Tanaka E, Mochida S, Murawaki Y, Honda M, Sakai A, Hiasa Y, Nishiguchi S, Koike A, Sakaida I, Imamura M, Ito K, Yano K, Masaki N, Sugauchi F, Izumi N, Tokunaga K, Mizokami M. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 2009; 41: 1105-1109 [PMID: 19749757 DOI: 10.1038/ng.449]
6. Rauch A, Kutalik Z, Descombes P, Cai T, Di Iulio J, Mueller T, Bochud M, Battegay M, Bernasconi E, Borovicka J, Colombo S, Cerny A, Dufour JF, Furrer H, Günthard HF, Heim M, Hirschel B, Malinverni R, Moradpour D, Müllhaupt B, Witteck A, Beckmann JS, Berg T, Bergmann S, Negro F, Telenti A, Bochud PY. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 2010; 138: 1338-145, 1338-145, [PMID: 20060832 DOI: 10.1053/j.gastro.2009.12.056]
7. Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML, Bassendine M, Spengler U, Dore GJ, Powell E, Riordan S, Sheridan D, Smedile A, Fragomeli V, Müller T, Bahlo M, Stewart GJ, Booth DR, George J. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 2009; 41: 1100-1104 [PMID: 19749758 DOI: 10.1038/ng.447]
8. McCarthy JJ, Li JH, Thompson A, Suchindran S, Lao XQ, Patel K, Tillmann HL, Muir AJ, McHutchison JG. Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin. Gastroenterology 2010; 138: 2307-2314 [PMID: 20176026 DOI: 10.1053/ j.gastro.2010.02.009]
9. Montes-Cano MA, García-Lozano JR, Abad-Molina C, Romero- Gómez M, Barroso N, Aguilar-Reina J, Núñez-Roldán A, González-Escribano MF. Interleukin-28B genetic variants and hepatitis virus infection by different viral genotypes. Hepatology 2010; 52: 33-37 [PMID: 20578254 DOI: 10.1002/hep.23624]
10. Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis 2010; 14: 1-21, vii [PMID: 20123436 DOI: 10.1016/j.cld.2009.11.009]
11. Osorio RG. O sistema classificatório de "cor ou raça" do IBGE. Brasília: Instituto de Pesquisa Econômica Aplicada 2003; 50: 1-51
12. Moreira S, Garcia RF, Gutberlet A, Bertol BC, Ferreira LE, Pinho Mde S, de França PH. A straightforward genotyping of the relevant IL28B SNPs for the prediction of hepatitis C treatment outcome. J Virol Methods 2012; 184: 93-97 [PMID: 22664181 DOI: 10.1016/j.jviromet.2012.05.024]
13. Ramos JA, Ramos AL, Hoffmann L, Perez Rde M, Coelho HS, Urményi TP, Silva R, Rondinelli E, Villela-Nogueira CA. A single nucleotide polymorphism, rs129679860, in the IL28B locus is associated with the viral kinetics and a sustained virological response in a chronic, monoinfected hepatitis C virus genotype-1 Brazilian population treated with pegylated interferon-ribavirin. Mem Inst Oswaldo Cruz 2012; 107: 888-892 [PMID: 23147144]
14. Elphick M, Yang JD, Cowen PJ. Effects of carbamazepine on dopamine- and serotonin-mediated neuroendocrine responses. Arch Gen Psychiatry 1990; 47: 135-140 [PMID: 02105705 DOI: 10.1016/j.gastrohep.2010.12.008]
15. Georgel P, Schuster C, Zeisel MB, Stoll-Keller F, Berg T, Bahram S, Baumert TF. Virus-host interactions in hepatitis C virus infection: implications for molecular pathogenesis and antiviral strategies. Trends Mol Med 2010; 16: 277-286 [PMID: 20537953 DOI: 10.1016/j.molmed.2010.04.003]
16. Lindh M, Lagging M, Arnholm B, Eilard A, Nilsson S, Norkrans G, Söderholm J, Wahlberg T, Wejstål R, Westin J, Hellstrand K. IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ ribavirin for chronic hepatitis C genotype 1. J Viral Hepat 2011; 18: e325-e331 [PMID: 21692944 DOI: 10.1111/ j.1365-2893.2010.01425.x]
17. Venegas M, Villanueva RA, González K, Brahm J. IL28B polymorphisms associated with therapy response in Chilean chronic hepatitis C patients. World J Gastroenterol 2011; 17: 3636-3639 [PMID: 21987611 DOI: 10.3748/wjg.v17.i31.3636]
18. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, Kidd J, Kidd K, Khakoo SI, Alexander G, Goedert JJ, Kirk GD, Donfield SM, Rosen HR, Tobler LH, Busch MP, McHutchison JG, Goldstein DB, Carrington M. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009; 461: 798-801 [PMID: 19759533 DOI: 10.1038/nature08463]
19. Fabris C, Falleti E, Cussigh A, Bitetto D, Fontanini E, Bignulin S, Cmet S, Fornasiere E, Fumolo E, Fangazio S, Cerutti A, Minisini R, Pirisi M, Toniutto P. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC. J Hepatol 2011; 54: 716-722 [PMID: 21146242 DOI: 10.1016/ j.jhep.2010.07.019]
20. Cavalcante LN, Abe-Sandes K, Angelo AL, Machado TM, Lemaire DC, Mendes CM, Pinho JR, Malta F, Lyra LG, Lyra AC. IL28B polymorphisms are markers of therapy response and are influenced by genetic ancestry in chronic hepatitis C patients from an admixed population. Liver Int 2012; 32: 476-486 [PMID: 22098416 DOI: 10.1111/j.1478-3231.2011.02653.x]
21. Lunge VR, da Rocha DB, Béria JU, Tietzmann DC, Stein AT, Simon D. IL28B polymorphism associated with spontaneous clearance of hepatitis C infection in a Southern Brazilian HIV type 1 population. AIDS Res Hum Retroviruses 2012; 28: 215-219 [PMID: 21790472 DOI: 10.1089/aid.2011.0096]
22. Shi X, Pan Y, Wang M, Wang D, Li W, Jiang T, Zhang P, Chi X, Jiang Y, Gao Y, Zhong J, Sun B, Xu D, Jiang J, Niu J. IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population. PLoS One 2012; 7: e37054 [PMID: 22649509 DOI: 10.1371/journal.pone.0037054]
23. Langhans B, Kupfer B, Braunschweiger I, Arndt S, Schulte W, Nischalke HD, Nattermann J, Oldenburg J, Sauerbruch T, Spengler U. Interferon-lambda serum levels in hepatitis C. J Hepatol 2011; 54: 859-865 [PMID: 21145813 DOI: 10.1016/ j.jhep.2010.08.020]